Orsay

HEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Foundation Fournier-Majoie and Noshaq

Retrieved on: 
Tuesday, January 23, 2024
Patient, Sarcoma, Biotechnology, Cancer, Ecosystem, GMP, Orsay, Oncology, TLR4, Investment, Pharmaceutical industry

HEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Foundation Fournier-Majoie and Noshaq

Key Points: 
  • HEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Foundation Fournier-Majoie and Noshaq
    1st institutional round for HEPHAISTOS-Pharma, getting on track to bring its lead product ONCO-Boost to the clinic.
  • HEPHAISTOS-Pharma, a biotechnology company developing next generation immunotherapies against cancer, today announced that it has raised a €2 million seed round to finance GMP transfer and advance its lead candidate towards the clinic.
  • The round was co-led by xista science ventures and the Foundation Fournier-Majoie, with the participation of Noshaq.
  • « The Foundation is very pleased to be part of HEPHAISTOS-Pharma thanks to this financing round.

EAT. DRINK. BE FRENCH.

Retrieved on: 
Monday, June 12, 2023
Olive, Ambassador, The Pierre, 21 West Street, Moules-frites, Steak tartare, Poultry, FRW, Culture, 60 (number), Chef, Brasserie Les Halles, À la carte, History, Restaurant Row, Orsay, 8 Spruce Street, Air France, OpenTable, Riviera, Restaurant, Coffee, Global Health Innovative Technology Fund, Bouchon, Pierre, Snails as food, Meat, Tourism, Sofitel, Elegance

NEW YORK, June 12, 2023 /PRNewswire/ -- MPB Agency is thrilled to announce the 12th edition of French Restaurant Week® this summer in New York as part of the Bastille Week festivities honoring French culture and history.

Key Points: 
  • French Restaurant Week continues to partner with OpenTable in New York where diners can easily book their reservations online throughout the event.
  • FRW is co-sponsored by GOURMAND bringing you the finest in quality cuisine ingredients such as: meat and poultry, charcuterie, mushrooms, truffles and more!
  • MPB Agency, LLC is an international public relations agency based in New York specializing in communications.
  • MPB Agency leads creative projects that develop branding for a variety of industries such as art de vivre, innovation & technology, culture and real estate.

Institut Curie Study Published in a Nature Journal Reporting Excellent Outcomes of Ibex's AI Solution for Breast Cancer Detection

Retrieved on: 
Wednesday, December 21, 2022
Cloud, Atypical ductal hyperplasia, Breast cancer, DCIS, Quality of life, Curie Institute (Paris), Trial of the century, Patient, HES, Pathology, CE, H&E, Harvard Medical School, Malignancy, Mucinous carcinoma of the breast, RUO, University, AI, Diagnosis, Maccabi Healthcare Services, FDA, MD, Laboratory, Education, Bureau of Oceans and International Environmental and Scientific Affairs, Oncology, Marie Cassidy, Algorithm, Survival, TEL, Deep learning, TILS, ADH, Physician, Incidence, Research, Cancer, Artificial intelligence, UK, Medical imaging, Medical device, Nature, Ibex, Orsay

TEL AVIV, Israel, and PARIS, Dec. 21, 2022 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, and Institut Curie, France's leading cancer center, today announced excellent outcomes in a clinical study validating and evaluating the clinical application of Ibex's Galen™ Breast. The study, conducted at Institut Curie in France and at Maccabi Healthcare Services in Israel, was published in Nature's peer reviewed npj Breast Cancer journal1.

Key Points: 
  • The study, conducted at Institut Curie in France and at Maccabi Healthcare Services in Israel, was published in Nature's peer reviewed npj Breast Cancer journal1 .
  • Breast cancer is the most common malignant disease worldwide, with over 2.2 million new cases each year3.
  • The images were analyzed by Ibex's Galen Breast solution, and the AI algorithm's output was assessed against a blinded consensus diagnosis of two breast pathologists.
  • Institut Curie, France's leading cancer centre, combines an internationally renowned research centre with a cutting-edge hospital group, which treats all types of cancer, including the rarest.

EQS-News: ABOUT YOU Holding SE: SCAYLE wins new customers with a sales volume of around EUR 100 million in 2022

Retrieved on: 
Saturday, October 22, 2022
Online, API, Depot, Non-fungible token, Commerce, Growth, Smartphone, The Oliver Group Champions Cup, B2B, Frankfurt Stock Exchange, Orsay, Entrepreneurship, SE, EUR, Technology, Digital, OMS, Goal, FC Bayern, Gen, Salesforce, Deichmann, SAP, CEO, Founding, PIM, CIO, FC Bayern Munich, Fielmann AG, Retail, Online shopping, Shopify, EU

With SCAYLE, the brands get the full range of ABOUT YOUs commerce infrastructure in a flexible solution as an enterprise cloud license product.

Key Points: 
  • With SCAYLE, the brands get the full range of ABOUT YOUs commerce infrastructure in a flexible solution as an enterprise cloud license product.
  • From the license and service contracts signed with the enterprise customers, SCAYLE secures a total sales volume of around EUR 100 million over the contract period.1 "Today, growth in e-commerce requires extremely high demands upon a shop system.
  • To achieve these goals, Europe's largest footwear retailer is migrating its brands DEICHMANN, Ochsner Sport, and vanHaren to SCAYLE.
  • SCAYLE provides ideal conditions for this and has convinced us with its great retail expertise," explains Sven-Severin Canisius, CIO at Deichmann.

Gordon Brothers Acquires ORSAY Brand & Partners with SCAYLE for Continued Growth

Retrieved on: 
Wednesday, August 3, 2022
DNA, Acquisition, SE, GLOBE, Orsay, Depot, Archive, Frankfurt Stock Exchange, Smartphone, Partnership, Solution, Commerce, Gordon Brothers, Founding, Technology, B2B, YOU, Entrepreneurship, Growth, Financial services, Retail, Online shopping, Cologne

Gordon Brothers acquisition allows the omni-channel womens fashion brand to maintain its brand DNA and develop new and exciting apparel, footwear and accessories.

Key Points: 
  • Gordon Brothers acquisition allows the omni-channel womens fashion brand to maintain its brand DNA and develop new and exciting apparel, footwear and accessories.
  • ORSAY will utilize SCAYLE, the B2B unit and infrastructure behind ABOUT YOU, with its B2B and distribution services.
  • The ORSAY brand has succeeded across regions, countries and distribution channels, and we are excited to partner with SCAYLE for its next chapter of growth.
  • Throughout this process, Gordon Brothers has shown an enthusiasm for the ORSAY brand, flexibility and readiness to ensure its continued presence in the European market, said Tarek Mller, Co-Founder and Co-CEO of ABOUT YOU and SCAYLE.